Covance has launched external laboratory management services that provide biopharma companies with a comprehensive management solution for external lab testing for clinical trials. A dedicated team within Covance’s central laboratory services will manage the new service.
The new service aims to maximize the quality and integrity of clinical study data by ensuring that specialty lab testing is managed for the client along with services provided by a central laboratory. These services include lab selection and qualification, auditing, vendor management, contracting and data cleaning.
“Through our external laboratory management services, ISO-15189 accreditation, and understanding of the regulatory landscape, Covance is uniquely positioned to enable our clients to meet higher levels of data scrutiny from agencies around the globe,” said Gary Paul, global director of Quality Assurance for Covance Central Laboratory Services. “As the pioneer of the central laboratory model, this new offering further establishes Covance’s position as a leader and innovator in clinical trials testing and sets a new industry standard for the management of data quality.”
Paul Kirchgraber, vice president Global Laboratory Operations & Medical Affairs, added, “By providing an enhanced laboratory data solution that reduces regulatory risk and lowers drug development cost, we enable our clients to focus on their core competencies, ultimately accelerating development and commercialization timelines.”